CV Sciences, Inc. 8-K
Research Summary
AI-generated summary
CV Sciences Files Regulation FD Disclosure; May 14, 2026 Press Release
What Happened
CV Sciences, Inc. (CVSI) filed a Current Report on Form 8-K on May 14, 2026 reporting a Regulation FD disclosure and furnishing a press release dated May 14, 2026. The filing is signed by CEO Joseph Dowling and includes the company’s Inline XBRL cover page.
Key Details
- Filing date: May 14, 2026 (Form 8-K).
- Reported items: Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits).
- Exhibit attached: Press Release of CV Sciences, Inc., dated May 14, 2026 (Exhibit 99.1).
- Signature: Report signed by Joseph Dowling, Chief Executive Officer, on May 14, 2026.
Why It Matters
A Regulation FD disclosure filing means the company publicly disclosed information to ensure fair access for all investors; the attached press release is the source of that disclosure. This 8-K does not itself report earnings, an executive change, or a merger — investors should read the May 14, 2026 press release for the specific content of the disclosure and any potential impact on CVSI’s business, quarterly results, or valuation.
Loading document...